Dechra's animal magic M&A
Recent M&A activity has super-charged Dechra Pharmaceuticals' (DPH) growth prospects and thisshould continue to justify a premium valuation.In the year to 30 June 2017 the veterinary products developer delivered sales growth of 28%...
27 July 2017